SCHEMBL5817702

SCHEMBL5817702

CN1CCN(C2CC(n3nc(-c4ccc(Oc5ccccc5)cc4)c4c(N)nccc43)C2)CC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BTK Q06187 15/20 0.64
LCK P06239 5/20 0.64
SRC P12931 4/20 0.64
TEK Q02763 4/20 0.64
KDR P35968 3/20 0.64
NUDT14 O95848 2/20 0.58
NUDT5 Q9UKK9 2/20 0.58
TNK2 Q07912 2/20 0.57
LYN P07948 2/20 0.50
PLK4 O00444 1/20 0.50
DCLK1 O15075 1/20 0.50
PDPK1 O15530 1/20 0.50
PRKD3 O94806 1/20 0.50
MAP4K4 O95819 1/20 0.50
PAK4 O96013 1/20 0.50
CHEK2 O96017 1/20 0.50
ABL1 P00519 1/20 0.50
EGFR P00533 1/20 0.50
ERBB2 P04626 1/20 0.50
NTRK1 P04629 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23239685 0.92 BTK (0.75) BTKLCKSRCTEKKDR
SCHEMBL23239684 0.92 BTK (0.75) BTKLCKSRCTEKKDR
SCHEMBL29844235 0.92 BTK (0.75) BTKLCKSRCTEKKDR
SCHEMBL23217530 0.92 BTK (0.75) BTKLCKSRCTEKKDR
SCHEMBL6434063 0.86 BTK (0.86) BTKLCKSRCTEKKDR
SCHEMBL22902484 0.85 BTK (0.55) BTKLCKSRCTEKKDR
SCHEMBL5815559 0.84 BTK (0.54) BTKLCKSRCTEKKDR
SCHEMBL6685312 0.84 BTK (0.56) BTKLCKSRCTEKKDR
SCHEMBL22902483 0.83 BTK (0.52) BTKLCKSRCTEKKDR
SCHEMBL5819015 0.82 LCK (0.61) BTKLCKSRCTEKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385524-A4 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO KG (DE) 2006-02-01 EP disclosed
EP-1385524-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS Abbott GmbH & Co. KG (DE) 2004-02-04 EP disclosed
WO-2002080926-A1 PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS ABBOTT GMBH & CO. KG (DE) 2002-10-17 WO disclosed